Inspiritol: A New Investigational Drug for ME/CFS and Long COVID
- Condition
- Long COVID
- At worst
- Not stated
- Ill for
- Not stated
- Published
- Oct 2021
Summary
Inspiritol, an investigational supplement, was used for 2 to 5 months by two unnamed long-COVID patients (evaluated alongside a third ME/CFS patient), though the page gives no specific dose or protocol. Researchers reported "dramatic improvement" in these patients' symptoms, with their immune profiles "modulating towards normal." The article explicitly flags this evidence as anecdotal and gives no detail on how long the improvement lasted or whether it faded.
Read it in their words
healthrising.org — this page sells a treatment, program or service.
What they credit
Credits Supplements, Inspiritol, transfer factor and other experimental immune.
Similar stories
-
Recovery Protocol Cheat Sheet
Christy's posted recovery protocol lists an extensive regimen: pre-protocol, three months of Eliquis 5 mg daily and clopidogrel 75 mg daily; from February 2024 a "foundation" of nutritional antivirals including matcha green tea, coconut oil, unpasteurized…
-
ATP working well for me
After COVID worsened his decades-old condition, Keshav began sublingual ATP and reports dramatic improvement within 3 days, and within 24 hours of his first injectable ATP dose felt his "mind was much sharper," mood and energy much better. Follow-up posts…